These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1576342)

  • 1. Multicenter clinical trial of 111In-CYT-103 in patients with ovarian cancer.
    Gallup DG
    Targeted Diagn Ther; 1992; 6():111-24. PubMed ID: 1576342
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
    Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 111In-CYT-103 on the surgical management of patients with ovarian cancer.
    Surwit EA
    Targeted Diagn Ther; 1992; 6():125-40. PubMed ID: 1576343
    [No Abstract]   [Full Text] [Related]  

  • 4. In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma.
    Neal CE; Baker MR; Hilgers RD; Fanning J; Burke RC; Snodgrass J; Cull RD
    Clin Nucl Med; 1993 Jun; 18(6):472-6. PubMed ID: 8319398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Cannistra SA
    Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
    [No Abstract]   [Full Text] [Related]  

  • 6. Oncoscint for detection of disseminated colorectal and ovarian cancer.
    Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients.
    Jusko WJ; Kung LP; Schmelter RF
    Targeted Diagn Ther; 1992; 6():177-90. PubMed ID: 1576345
    [No Abstract]   [Full Text] [Related]  

  • 8. OncoScint image atlas.
    Maguire RT
    Targeted Diagn Ther; 1992; 6():141-75. PubMed ID: 1576344
    [No Abstract]   [Full Text] [Related]  

  • 9. Challenges in immunoscintigraphy of ovarian cancer.
    Kim EE; Kasi LP
    Gynecol Oncol; 1993 Mar; 48(3):283-4. PubMed ID: 8462895
    [No Abstract]   [Full Text] [Related]  

  • 10. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
    Abdel-Nabi HH; Doerr RJ
    Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
    Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW
    Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
    Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
    Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
    Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
    Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
    Doerr RJ; Abdel-Nabi HH
    Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioimmunodetection of colorectal carcinoma.
    Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
    Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical approach to planar and SPECT imaging of 111In-CYT-103.
    Collier BD; Trembath LA; Liu Y; Turoglu HT; Patel N; Thakur S
    Targeted Diagn Ther; 1992; 6():191-210. PubMed ID: 1576346
    [No Abstract]   [Full Text] [Related]  

  • 17. In-111 CYT-103 immunoscintigraphy of isolated splenic metastasis from ovarian carcinoma.
    Nguyen BD; Regan F
    Clin Nucl Med; 1997 Apr; 22(4):256-7. PubMed ID: 9099487
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report.
    Method MW; Serafini AN; Averette HE; Rodriguez M; Penalver MA; Sevin BU
    Cancer; 1996 Jun; 77(11):2286-93. PubMed ID: 8635097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoscintigraphy of prostatic cancer].
    Aliaev IuG; Vinarov AZ; Rapoport LM; Bezrukov EA; Butnaru DV
    Urologiia; 2006; (4):67-9. PubMed ID: 17058687
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibody imaging of colorectal and ovarian cancer.
    Haseman MK
    West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.